Article,

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

, , , , , , , , , , , , and .
Cell, 181 (2): 271-180 (April 2020)
DOI: https://doi.org/10.1016/j.cell.2020.02.052

Meta data

Tags

Users

  • @fordham1

Comments and Reviews